The root of Actinidia deliciosa has been used as traditional drugs in China for a long time. This study therefore aimed at investigating the hepatoprotective bio-active components from the root of A. deliciosa comprehensively and accurately, thus promoting the exploitation and utilization of the whole resource of A. deliciosa. For the purpose of this study, the roots of A. deliciosa were fractionated into various extract fractions with differential polarity solvent. The hepatoprotective activities of various solvent extracts were assessed by examining the effect on carbon tetrachloride (CCl 4 )-induced hepatotoxicity in rats. The highest hepatoprotective activities fraction was further isolated with column chromatography. The structures of the activities monomers were identified with modern spectrum technology such as infrared (IR), ultraviolet (UV), electron impact mass spectrometry (EI-MS), proton nuclear magnetic resonance ( 
INTRODUCTION
Liver intoxication has increased as a result of exposure to high levels of environmental toxins, since the liver has an *Corresponding author. E-mail: xinpeng2001@126.com or xinpeng2011@gmail.com. Tel: ++86 898 6619 6803. Fax: ++86 898 6619 3581.
important role in detoxification and most of the liver damage are induced by lipid peroxidation and other oxidative damages caused by the hepatotoxic chemicals (Appiah et al., 2009; Muhtaseb et al., 2008; Subramoniam and Pushpangadan, 1999) . Carbon tetrachloride (CCl 4 ) is a well know hepatotoxin that is widely used to study the induction of toxic liver injury in a range of laboratory animals (Appiah et al., 2009 ). Antioxidation plays an important role in protecting against carbon tetrachlorideinduced liver injury (Ardanaz and Pagano, 2006) .
In recent years, Chinese herbal medicine has attracted many attentions from researchers in various areas. A number of medicinal preparations in Chinese herb have been recommended for the treatment of liver disorders (Chatterjee, 2000) . Actinidia deliciosa is subfamily of the genus Actinidia, and is widely distributed in the Asian continent. The fruit of A. deliciosa has been acclaimed for its native and medicinal values. The root of A. deliciosa has been used as traditional drugs in China for a long time; it was reported as a folk remedy for adult diseases, as a potent anti-hepatotoxic, and against pyorrhea and gingival inflammation (Jiangsu New Medical College, 1997) . Furthermore, the ethanol extracts of A. deliciosa root had been proven to possess anticancer properties in vitro (Zhong et al., 2004) and in vivo (Li, 2001 ). The active compounds from A. deliciosa have been separated and identified; 5 compounds were isolated and identified as: 2α,3β,19,23-tetrahydroxylolean -12-en-28-oic acid (I), 2α,3α,23-trihydroxy-urs-12-en-28-oic acid(II), 2α,3β,19,23 -tetrahydroxyl-urs-12en-oic acid(III), undecanoic acid(IV), beta-sitosterol (V) (Lai and Xu, 2007) . The current authors have also reported that the ethanol extracts from roots of A. deliciosa have anti-hepatotoxic effects (Bai et al., 2007) , and could have effect on liver pathological changes (Bai and Qiu, 2006) . However, the hepatoprotective main chemical constituents of A. deliciosa root have not been previously investigated in a systematic way.
Based on our previous studies (Bai et al., 2007; Bai and Qiu, 2006) , we envisaged a study of the hepatoprotective potentials and chemistry of the plant, particularly its root parts, so as to provide a scientific basis to its usefulness in ameliorating the liver dysfunction. Therefore, in the present study, we utilized various exactions obtained from A. deliciosa root for an evaluation of its hepatoprotective potentials, employing a sequence of tests in various experimental models of carbon tetrachloride (CCl 4 )-induced hepatotoxicity. A bioassay based fractionation of 60% ethanol extract of A. deliciosa root led us to the identification of active fraction here after called as 'TF'. The bioactive fraction has been standardized on the basis of their physical characteristics and spectral data to obtain three major triterpenoid namely 3β-hydroxy-urs-12-en-28-oic acid (I); 2α, 3α, 3β, 19, (Figure 1 ). This paper reports the therapeutic potential of TF as a hepatoprotective agent and its main chemical constituents.
MATERIALS AND METHODS

Chemicals
Assay kits for measuring serum alanine transaminase (ALT), Bai et al. 14483 aspartate transaminase (AST) activities, hepatic lipid peroxidation (malondialdehyde (MDA)) and glutathione (GSH) were purchased from Nanjing Biomedical. Ltd. (Nanjing, China 
Preparation of extracts and identification of active fraction
The dried and powdered A. deliciosa root (10 kg) was extracted with 60% ethanol (v/v) (60 L ×3) under 45°C for 8 h each time. Next, the combined extract was cooled to room temperature (25°C), filtered through muslin and then the filtrate was concentrated under reduced pressure (45°C, 0.1 MPa, 3 h) and freeze-dried (24 h) to produce a 60% ethanol crude extract (Fr1) (2.06 kg). The yield on the dry root corresponded to 20.60%. The extract (Fr1) (1000 g) so obtained was suspended in water (3000 ml) and extracted successively with n-hexane, ethyl acetate and n-butanol (3 × 5 L each) to obtain four fractions: a n-hexane extract (Fr2) (89.2 g, yield, 1.84%), an ethyl acetate extract (Fr3) (348.6 g, yield, 7.18%), n-butanol extract (Fr4) (229.5 g, yield, 4.73%) and aqueous portion (Fr5) (257.3 g, yield, 5.30%) after removal of the solvent in vacuum. All the fractions were subjected to screening of hepatoprotective activity (preventive and curative study) against CCl4 induced hepatic injury in rats on limited test models, which led to establishing that Fr3 and Fr4 possessed significant hepatoprotective activity, while the Fr3 was more potent over the Fr4.
Keeping in view the percent yield and bio-activity, the Fr3 was further taken up for detailed hepatoprotective activity. The active fraction Fr3 (175 g) was also subjected to column chromatography on Diaion HP-20 with a successive elution system of water: ethanol (100:0 to 5:95) to obtain five fractions (Fr6 -Fr10): Fr6 (14.6 g, yield, 0.6%), Fr7 (21.7 g, yield, 0.89%), Fr8 (30.5g, yield, 1.25%), Fr9 (TF, 50:50 to 30:70 elution part) (52.6 g, yield, 2.16%) and Fr10 (26.2 g, yield, 1.07%). All these fractions were biologically evaluated against CCl4-induced hepatic injury in rats (prophylactic study) for ALT, AST, hepatic lipid peroxidation and GSH to identify the active fraction eliciting maximum hepato-protection, which was taken up for further studies. On detailed chemical analysis, the active fraction Fr9 (TF) was found to be a mixture of triterpenoid, resolving into three major spots on thin layer chromatography (TLC) (chloroform: methanol, 70:30, one spots Rf values were equivalent to ursolic acid) and some minor spots. Fr9 (TF) (20 g) was subjected to column chromatography on Sephadex-LH-20 for the separation and identification of individual components. On elution with water: ethanol (90: 10 to10: 90), the three major fractions FrI, FrII and FrIII could be separated. Fraction FrI, FrII and FrIII were purified by silica gel H and RP-18 gel column chromatography to give compound I (450 mg), compound II (210 mg) and compound III (150 mg). These compounds were identified on the basis of their physical characteristics and spectral data. 
Animal treatment
Charles Foster rats (150 -180 g) of either sex, procured from Hainan Medical University (SCXK(Su)2009-0004, Hainan China) were used for the study. The animals were housed in large polypropylene cages and allowed free access to Purina Rodent Chow and tap water, maintained in a controlled environment at 20 ± 2°C and 50 ± 5% relatively humidity with a 12-h dark/light cycle, and acclimatized for at least one week before use. The grouping of the animals and the treatment regimens both for pre-and posttreatment of extracts fractions and silymarin against CCl4 hepatotoxins is described in Table 1 . A different set of animals was used for each experimental model. Freshly prepared suspension of extracts (2% w/v) and TF (1%, w/v) in normal saline were used in all the experiments against hepatotoxins; the control animals were given the vehicle only (Table 1) .
Induction of hepatic damage
Liver injury was produced by administration of CCl4 mixed with olive oil (1:1). A single dose of CCl4 (1 ml/kg) was given to rat in both in preventive and curative studies by gastric intubation. The control animals received an equal volume of olive oil (Vogel, 1977) (Table  1) .
Preparation of serum and liver homogenate
Blood was collected from the orbital sinus of all the animals and the serum was separated for various biochemical estimations. After the collection of blood, animals were sacrificed by decapitation and the liver was removed free of adhering tissues, perfused with cold saline, cut into small pieces blotted and weighed, and then minced and homogenized in glass homogenizer at 1100 rpm for 2 min in cold 10 mM Tris-HCl buffer (pH 7.4) so as to obtain 10% WH (Schenkman and Cinti, 1978) for the estimation of GSH and lipid peroxidation.
Assay of hepatoprotectivity
Serum was used for assaying ALT and AST (Reitman and Frankel, 1957) , and the liver whole homogenate for lipid peroxidation (Wills, 1969; Fairhurst et al., 1982) and GSH (Ellman, 1959; Sedlak and Lindsay, 1968) .
Statistical analysis
The data were expressed as mean ± standard error of mean (S.E.M; n = 6). Results were analyzed statistically by one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison using SPSS software student's version. The p value of < 0.05 or less was taken as the criterion of significance.
Identification of active fraction main compound
Melting points were taken on the Japanese Yanaco micro melting point apparatus and uncorrected. Infrared (IR) spectra were recorded on the Hitachi 270~50 Infrared Spectrophotometer in KBr discs. Electron impact mass spectrometry (EI-MS) data were recorded on the HP 5989A, JMS-D300 and Variam MAT 212 instrument. Proton nuclear magnetic resonance ( 1 H NMR) and carbon nuclear magnetic resonance ( 13 C NMR) spectra were recorded with BRUKER AM-400 and/or DRK-500 Spectrometer using tetramethylsilane (TMS) as internal standard. Chromatographic separations were carried out on Diaion HP-20 (Nanjing, China), Sephadex-LH-20 (Shanghai, China), silica gel H and RP-18 gel column and TLC on silica gel GF254 (Yantai, China).
Prophylactic study (Serum parameters) Curative study (Serum parameters) ALT(U/L) AST(U/L) ALT(U/L) AST(U/L)
RESULTS AND DISCUSSION
Effect of various extracts of A. deliciosa root on serum biochemical parameters against CCl 4-induced hepatic injury in rats (prophylactic and curative studies)
The results of the studies are summarized in Table 2 . With treatment by CCl 4 , the activities of ALT and AST in rat's serum increased by 624.00 and 601.80% (in prophylactic studies), and 1421.34 and 614.51% (in curative studies) compared to that of the normal control group, respectively. This result indicates that a single dose of CCl 4 : olive oil (1:1, 1 ml/kg) causes hepatotoxicity in rats. The activities of ALT and AST were significantly (p < 0.01) increased in CCl 4 control compared to normal control. Moreover, the results with different extracts showed that all the extracts are effective against the acute CCl 4 -induced hepatic damage in rats as evidenced from recovery of altered parameters. However, the Fr3 and Fr4 produced comparable protection that the effect is relatively higher than other extracts and reference drugs. Of five different extracts, Fr3 had higher hepatoprotective effect than Fr1, Fr2, Fr4 and Fr5 at the dose of 60 mg/kg (p<0.05) ( 393.12 ± 24.62 U/L, decreased 55.64 and 45.17%, compared with that of CCl 4 control group hepatotoxicity, respectively which produce relatively higher (in prophylactic studies) and equivalent (in curative studies) effect, compared with silymarin.
Comparable evaluation of different fractions of Fr3 on biochemical parameters in rats against CCl 4 -induced hepatic injury (prophylactic study)
In order to identify the hepatoprotective active fraction, five fractions Fr6-Fr10 obtained from the Fr3 were further studied. The results of the studies are summarized in Table 3 . The CCl 4 administration significantly (p <0.01) increased the level of the rats serum ALT, AST and hepatic lipid peroxidation while significantly (p <0.01) decreased the level of hepatic GSH. A single pretreatment with each fraction of Fr3 shows that all the fractions are effective against acute hepatic damage caused by CCl 4 . However, of five different extracts (Fr6 -Fr10), Fr9 has relatively higher hepatoprotective effect than other extracts and reference drugs at the dose of 60 mg/kg (p<0.05) ( Table 3 ). With treatment of Fr9, the activities of ALT and AST from 1120.68 ± 57.1 U/L and 1042.69 ± 39.56 U/L decreased to 421.33 ± 37.35 and 430.96 ± 36.92 U/L, decrease 62.4% and 58.67%, compared with that of CCl 4 control group hepatotoxicity, respectively. The fraction Fr9 was more promising even when compared with silymarin.
The levels of GSH and lipid peroxidation for each group of livers were also determined due to the fact that oxidative stress of tissue generally involves the GSH system and lipid peroxidation. As illustrated in Table 3 , the level of lipid peroxidation in the CCl 4 -induced rat liver decreased using different fraction of Fr3, and the lipid peroxidation was at the minimal level (76.61 ± 4.49 nmol/g liver) when CCl 4 -induced liver was treated by Fr 9 (Table 3) . Moreover, Fr 9 prevented the depletion of hepatic GSH level. When normal liver was treated by CCl 4 , the GSH level decreased 62.97%, from 6.13 ± 0.22 to 2.27 ± 0.12 μmole/g liver. However, with treatment of 60 mg/kg Fr9, the concentration of GSH only decreased by 14.77% from 6.13 ± 0.22 to 5.22 ± 0.27 μmole/g liver. This value is lower than that of silymarin-treat sample (Table 3) .
Pre-and post-treatment of different dose Fr 9 (TF) against CCl 4 -induced hepatic injury in rats
The effects of different dose Fr 9 (TF) on CCl 4 -induced hepatotoxicity in rats were investigated and shown in Tables 4 and 5. Administration of CCl 4 alone resulted in a significant increase in normal levels of serum and hepatic parameters (Tables 4 and 5 Post-treatment with TF also showed significant reversal of these elevated levels in a dose-related manner for ALT, AST, lipid peroxidation and GSH (Tables 5). When at the dose of 200 mg/kg TF was used in treating the CCl 4 -induced rat. The activities of ALT, AST and lipid peroxidation attained low levels, decreasing by 88.60, 79.92 and 45.53%, while the level of GSH increased by 147.62% respectively compared with that of the CCl 4 control group hepatotoxicity (Tables 5). Moreover, the levels of biochemical parameters ALT, AST, Lipid peroxidation and GSH were not significantly different from the vehicle control by Dunnett's t test (Tables 5).
Identification of the main constituents of TF
Compound I (Figure 1) Table 6 ; the spectral data are in agreement with those reported in the literature (Srivasta and Jain, 1989; Gong, 1986) .
Compound II (Figure 1 ) was obtained as a white powder, and it gave a positive coloration with the Liebermann-Burchard test for triterpenoids. Mp 308~310°C. IR ν max (cm -1 ): 3444.14, 2923.07, 2852.90, 1689.18, 1462.26, 1376.90,1033.79 Table 6 ; the spectral data are in agreement with those reported in the literature (Gong, 1986, Lai and Xu, 2007) .
Compound III (Figure 1) Table 6 ; the spectral data are in agreement with those reported in the literature (Gong, 1986, Lai and Xu, 2007) .
In the present study, the in vivo hepatoprotective activity of different extracts of A. deliciosa root was assessed by monitoring different serum and hepatic biochemical parameter status using an active fraction (TF), which was obtain from the activity directed fractionation of aqueous alcoholic extract of A. deliciosa root, against CCl 4 -induced hepatotoxicity (Tables 2 to 5 ). Oral administration of TF showed significant hepato-protective activity both in preventive and curative treatments against CCl 4 -induced hepatic damage (Tables 4 and 5) , and subsequent recovery towards normalization of these enzymes at a dose 200 mg/kg. The leakage of hepatic housekeeping enzymes such as ALT, AST is commonly used as an indirect biochemical index of hepatocellular damage (Recknagel and Lombardi, 1961; Klaassen and Watkin, 1984) . The extent of hepato-protection afforded by the extracts and TF against the chemically induced hepatic injury can be compared on the basis of serum and hepatic parameters (Tables 3 to 5) .
It is well established that the pathogenesis of CCl 4 -induced hepatotoxicity associated with the substantial increase in lipid per-oxidation as was evident from elevated MDA level in liver homogenate with a concurrent fall in hepatic GSH content, which was very much supportive with the strong hepatotoxic response of these experimental models (Klaassen and Watkin, 1984; Burk, 1983) . Treatment with TF significantly reversed and restored these altered level of these parameters to normal (Tables 4 and 5 ). The studied result suggests that oral administration of TF has a beneficial effect on the hepato-protection as observed in the present study. However, based on the results illustrated in the present study, it may be suggested that the use of TF for treatment of chemical, drug, viral or pollutant mediated hepatic ailments is well justified as it has inhibited the hepatocellular metabolic alterations that are mediated by CCl 4 treatments. These findings confirm its reported therapeutic value in traditional system of medicine and dispersal by herbal dealers in liver ailments. Further studies using some more models of experimental injury may help to establish a definite rationale for its therapeutic exploration as a potent hepatoprotective drug.
Conclusion
From the overall results, it can be concluded that the TF exhibited high hepatoprotective activities in vivo in a dose-related manner as indicated by the action against CCl 4 toxicity. The hepatoprotective action may be mainly mediated by the enhancement of hepatic glutathione regeneration capacity and decreased level of lipid peroxidation, particularly under conditions of CCl 4-induced oxidative stress. The main chemical constituents of TF are three triterpenoids, namely 3β-hydroxy-urs-12-en-28-oic acid (I); 2α, 3α, 23-trihydroxy-urs-12-en-28-oic acid (II); 2α, 3β, 19, 23-tetrahydroxy-urs-12-en-28-oic acid (III).
